• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美敦力-霍尔瓣膜5年随访:生存率与血栓栓塞情况

A 5-year follow-up of the Medtronic-Hall valve: survival and thromboembolism.

作者信息

Semb B K, Hall K V, Nitter-Hauge S, Abdelnoor M

出版信息

Thorac Cardiovasc Surg. 1983 May;31 Spec 2:61-5. doi: 10.1055/s-2007-1022031.

DOI:10.1055/s-2007-1022031
PMID:6192536
Abstract

Throughout the period 1977 to 1982, 436 patients underwent aortic valve replacement (AVR), 106 underwent mitral valve replacement (MVR) and 56 patients underwent double valve replacement (DVR), with the Medtronic-Hall prosthetic valve (previous equivalent: Hall-Kaster valve). Early and late mortality were 4% and 9% for AVR, 8% and 11% for the MVR and 7% and 13% in the DVR, respectively. Actuarial survival after 5 years of follow-up was 80.9% for AVR, 75.4% for MVR and 81.0% for the DVR. Thromboembolic complications included 2 cases of valve thrombosis in the AVR, in one case secondary to valve endocarditis. Eleven further thromboembolic episodes occurred in 10 patients with AVR. In MVR an aspergillus thrombus was found on the valve at autopsy in a patient dying from multiple cerebral aspergillus abscesses. Five further thromboembolic episodes occurred in 4 patients with MVR. In the DVR group there was one valve thrombosis and one further patient with a thromboembolic episode. The actuarial probability of remaining free from thromboembolism at the end of the 5 years of follow-up was 92.5% for AVR and 83.7% for MVR.

摘要

在1977年至1982年期间,436例患者接受了主动脉瓣置换术(AVR),106例接受了二尖瓣置换术(MVR),56例患者接受了双瓣膜置换术(DVR),均使用美敦力-霍尔人工瓣膜(先前等效物:霍尔-卡斯特瓣膜)。AVR的早期和晚期死亡率分别为4%和9%,MVR为8%和11%,DVR为7%和13%。随访5年后的精算生存率,AVR为80.9%,MVR为75.4%,DVR为81.0%。血栓栓塞并发症包括AVR中有2例瓣膜血栓形成,其中1例继发于瓣膜心内膜炎。另外10例接受AVR的患者发生了11次血栓栓塞事件。在MVR中,1例死于多发性脑曲霉菌脓肿的患者尸检时发现瓣膜上有曲霉菌血栓。另外4例接受MVR的患者发生了5次血栓栓塞事件。在DVR组中,有1例瓣膜血栓形成,另有1例患者发生血栓栓塞事件。随访5年末无血栓栓塞的精算概率,AVR为92.5%,MVR为83.7%。

相似文献

1
A 5-year follow-up of the Medtronic-Hall valve: survival and thromboembolism.美敦力-霍尔瓣膜5年随访:生存率与血栓栓塞情况
Thorac Cardiovasc Surg. 1983 May;31 Spec 2:61-5. doi: 10.1055/s-2007-1022031.
2
Eighteen-year follow up after Hancock II bioprosthesis insertion.汉考克二代生物假体植入术后18年随访。
J Heart Valve Dis. 1999 Jan;8(1):16-24.
3
[Early and late results of St. Jude Medical prosthesis in aortic and mitral portion].[圣犹达医疗公司人工心脏瓣膜在主动脉和二尖瓣部位的早期及晚期效果]
Rinsho Kyobu Geka. 1989 Aug;9(4):374-80.
4
Clinical evaluation of the carbomedics prosthesis: experience at providence health system in Portland.卡波美迪克斯人工关节的临床评估:波特兰普罗维登斯健康系统的经验
J Heart Valve Dis. 2002 Nov;11(6):844-50.
5
A 5 year experience with the Medtronic-Hall disc valve prosthesis.美敦力 - 霍尔碟瓣人工心脏瓣膜的5年使用经验。
Circulation. 1983 Sep;68(3 Pt 2):II169-74.
6
A 10-year experience with the Carbomedics cardiac prosthesis.使用Carbomedics心脏瓣膜假体的10年经验。
Ann Thorac Surg. 2005 Mar;79(3):784-9. doi: 10.1016/j.athoracsur.2004.08.067.
7
Early clinical experience with the On-X prosthetic heart valve.On-X人工心脏瓣膜的早期临床经验。
J Heart Valve Dis. 2001 Jan;10(1):94-9.
8
Ten-year experience with the Medtronic Hall valvular prosthesis. A study of 1,104 patients.美敦力霍尔瓣膜假体的十年经验。对1104例患者的研究。
Circulation. 1989 Sep;80(3 Pt 1):I43-8.
9
Five-year follow up of the ATS mechanical heart valve.美国胸科学会(ATS)机械心脏瓣膜的五年随访
J Heart Valve Dis. 2004 Mar;13(2):231-8.
10
Carpentier-Edwards bioprosthesis: a 7-year follow-up in 361 patients.卡朋蒂埃-爱德华兹生物瓣膜:361例患者的7年随访
Thorac Cardiovasc Surg. 1986 Aug;34(4):252-7. doi: 10.1055/s-2007-1020422.